{"id":5431,"date":"2020-09-03T14:55:26","date_gmt":"2020-09-03T11:55:26","guid":{"rendered":"https:\/\/by-tv.co.uk\/?p=5431"},"modified":"2020-09-03T14:55:26","modified_gmt":"2020-09-03T11:55:26","slug":"oxfordun-gelistirdigi-kovid-19-asi-adayinin-abdde-ucuncu-asama-klinik-denemeleri-basladi","status":"publish","type":"post","link":"https:\/\/by-tv.co.uk\/en\/oxfordun-gelistirdigi-kovid-19-asi-adayinin-abdde-ucuncu-asama-klinik-denemeleri-basladi\/","title":{"rendered":"Oxford’un geli\u015ftirdi\u011fi Kovid-19 a\u015f\u0131 aday\u0131n\u0131n ABD’de \u00fc\u00e7\u00fcnc\u00fc a\u015fama klinik denemeleri ba\u015flad\u0131"},"content":{"rendered":"
\n

“Clinical Trials Arena” internet sitesinde yer alan habere g\u00f6re, \u0130ngiltere’de Oxford<\/span>\u00a0\u00dcniversitesinin \u0130ngiliz-\u0130sve\u00e7 ila\u00e7 \u015firketi AstraZeneca i\u015f birli\u011finde geli\u015ftirdi\u011fi “AZD1222” adl\u0131\u00a0yeni tip koronavir\u00fcs\u00a0(Kovid-19)\u00a0a\u015f\u0131 aday\u0131\u00a018 ya\u015f \u00fcst\u00fc 30 bin denek \u00fczerinde test edilecek.<\/p>\n

ABD Biyomedikal \u0130leri Geli\u015ftirme \u0130daresi (BARDA) ve Ulusal Alerji ve Bula\u015f\u0131c\u0131 Hastal\u0131klar Enstit\u00fcs\u00fcn\u00fcn (NIAID) deste\u011fiyle ger\u00e7ekle\u015ftirilen deneme, a\u015f\u0131 aday\u0131n\u0131n g\u00fcvenlik, etkinlik ve ba\u011f\u0131\u015f\u0131kl\u0131k etkisini kitlesel \u00f6l\u00e7ekte s\u0131namay\u0131 hedefliyor.<\/p>\n

\u0130nsanlarda basit so\u011fuk alg\u0131nl\u0131\u011f\u0131na yol a\u00e7an bir adenovir\u00fcs\u00fcn zay\u0131flat\u0131lm\u0131\u015f ve kendini \u00e7o\u011faltamayan versiyonunu i\u00e7eren a\u015f\u0131 aday\u0131, Kovid-19’un insan h\u00fccrelerine tutunmas\u0131n\u0131 sa\u011flayan \u00e7ivi proteininin yapay \u015fekilde ifade kazanmas\u0131n\u0131 ve v\u00fccudun buna kar\u015f\u0131 koruyucu antikorlar \u00fcreterek ger\u00e7ek vir\u00fcse ba\u011f\u0131\u015f\u0131kl\u0131k kazanmas\u0131n\u0131 ama\u00e7l\u0131yor.<\/p>

\"\"<\/a><\/div>\n

A\u015f\u0131 aday\u0131n\u0131n birinci ve ikinci a\u015fama klinik denemeleri \u0130ngiltere ve G\u00fcney Afrika’da y\u00fcr\u00fct\u00fclm\u00fc\u015f, Brezilya’da 5 bin dene\u011fin kat\u0131ld\u0131\u011f\u0131 \u00fc\u00e7\u00fcnc\u00fc a\u015fama klinik denemelere ba\u015flanm\u0131\u015ft\u0131.<\/p>\n

Klinik denemeler 3 a\u015famada yap\u0131l\u0131yorBir a\u015f\u0131n\u0131n yayg\u0131n olarak kullan\u0131labilmesi i\u00e7in 3 a\u015famada insanlar \u00fczerinde test edilmesi gerekiyor.<\/p>\n

Klinik denemelerin ilk a\u015famas\u0131nda, az say\u0131daki g\u00f6n\u00fcll\u00fc sa\u011fl\u0131kl\u0131 denek \u00fczerinde a\u015f\u0131n\u0131n g\u00fcvenli olup olmad\u0131\u011f\u0131 ve olas\u0131 yan etkileri ara\u015ft\u0131r\u0131l\u0131yor. \u0130kinci a\u015famada, g\u00fcvenilirli\u011fi do\u011frulanan a\u015f\u0131n\u0131n etkinli\u011fi 100’den fazla denek \u00fczerinde test ediliyor. \u00dc\u00e7\u00fcnc\u00fc ve son a\u015famada ise ayn\u0131 i\u015flem, binlerce denekle tekrarlan\u0131yor. T\u00fcm bu s\u00fcre\u00e7, aylar ve hatta y\u0131llar alabiliyor.<\/p>\n

33 a\u015f\u0131 aday\u0131, klinik deneme a\u015famas\u0131ndaD\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (DS\u00d6) verilerine g\u00f6re, 28 A\u011fustos itibar\u0131yla d\u00fcnya genelinde Kovid-19’a kar\u015f\u0131 33 a\u015f\u0131 aday\u0131 klinik deneme, 143 a\u015f\u0131 aday\u0131 ise klinik \u00f6ncesi de\u011ferlendirme a\u015famas\u0131nda bulunuyor.<\/p>\n

\u00c7in’de ortaya \u00e7\u0131kan Kovid-19, 200’den fazla \u00fclke ve b\u00f6lgeye yay\u0131larak salg\u0131na d\u00f6n\u00fc\u015ft\u00fc. D\u00fcnya genelinde vaka say\u0131s\u0131 26 milyona yakla\u015f\u0131rken, 861 binden fazla ki\u015fi hayat\u0131n\u0131 kaybetti.<\/p>\n

AA<\/p>\n<\/div>\n

\n
<\/div>\n<\/div>\n
\"\"<\/a><\/div>","protected":false},"excerpt":{"rendered":"

“Clinical Trials Arena” internet sitesinde yer alan habere g\u00f6re, \u0130ngiltere’de Oxford\u00a0\u00dcniversitesinin \u0130ngiliz-\u0130sve\u00e7 ila\u00e7 \u015firketi AstraZeneca i\u015f birli\u011finde geli\u015ftirdi\u011fi “AZD1222” adl\u0131\u00a0yeni tip koronavir\u00fcs\u00a0(Kovid-19)\u00a0a\u015f\u0131 aday\u0131\u00a018 ya\u015f \u00fcst\u00fc 30 bin denek \u00fczerinde test edilecek. ABD Biyomedikal \u0130leri Geli\u015ftirme \u0130daresi (BARDA) ve Ulusal Alerji ve Bula\u015f\u0131c\u0131 Hastal\u0131klar Enstit\u00fcs\u00fcn\u00fcn (NIAID) deste\u011fiyle ger\u00e7ekle\u015ftirilen deneme, a\u015f\u0131 aday\u0131n\u0131n g\u00fcvenlik, etkinlik ve ba\u011f\u0131\u015f\u0131kl\u0131k etkisini kitlesel \u00f6l\u00e7ekte s\u0131namay\u0131 hedefliyor. \u0130nsanlarda basit so\u011fuk alg\u0131nl\u0131\u011f\u0131na yol a\u00e7an bir adenovir\u00fcs\u00fcn zay\u0131flat\u0131lm\u0131\u015f ve kendini \u00e7o\u011faltamayan versiyonunu i\u00e7eren a\u015f\u0131 aday\u0131, Kovid-19’un insan h\u00fccrelerine tutunmas\u0131n\u0131 sa\u011flayan \u00e7ivi proteininin yapay \u015fekilde ifade kazanmas\u0131n\u0131 ve v\u00fccudun buna kar\u015f\u0131 koruyucu antikorlar \u00fcreterek ger\u00e7ek vir\u00fcse ba\u011f\u0131\u015f\u0131kl\u0131k kazanmas\u0131n\u0131 ama\u00e7l\u0131yor. A\u015f\u0131 aday\u0131n\u0131n […]<\/p>\n","protected":false},"author":1,"featured_media":5101,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[11],"tags":[1565,1656,708],"class_list":["post-5431","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dunya","tag-astrazeneca","tag-barda","tag-oxford"],"_links":{"self":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/5431","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/comments?post=5431"}],"version-history":[{"count":0,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/5431\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media\/5101"}],"wp:attachment":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media?parent=5431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/categories?post=5431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/tags?post=5431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}